Efficacy of treating very low birth weight and critical ill neonates with erithropoietin in the first 72 h of age: A randomized, placebo-controlled trial;Eficacia del uso precoz de eritropoyetina en recién nacidos pretérmino de muy bajo peso, críticamente enfermes: Ensayo clínico controlado

Sangre

Volumn 43, Issue 3, 1998, Pages 191-195

  Lima Rogel, Victoria ^a   Torres Montes, Abraham ^a,c   Griesse, Salvador Espinosa ^a   Alvarez, Carolina Villegas ^a   Hernández Sierra, Francisco ^b   Mandeville, Peter Bissett ^b   González, Cecilia Correa ^a  

^a HOSPITAL CENTRAL DR IGNACIO MORONES PRIETO   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^c Edificio Médica San Luis ^*  (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN; RECOMBINANT PROTEIN;

ANEMIA; ARTICLE; CLINICAL TRIAL; DRUG ADMINISTRATION; ERYTHROCYTE TRANSFUSION; HEMATOCRIT; HUMAN; INTENSIVE CARE; NEWBORN; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UTILIZATION REVIEW; VERY LOW BIRTH WEIGHT;

ANEMIA; CRITICAL CARE; DRUG ADMINISTRATION SCHEDULE; ERYTHROCYTE TRANSFUSION; ERYTHROPOIETIN; HEMATOCRIT; HEMOGLOBINS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

EID: 0032088859     PISSN: 00364355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Greenhound A, Milner A, Clifford R. Neonatal respiratory disorders. Londres, Oxford University Press, 1996.
2. Hack M, Horbar J, Malloy M, Tyson J, Wright E, Wright L. Vary low birth weight outcomes of the national institute of child health and human development neonatal work. Pediatr 1991; 87: 587-597.
3. Emmerson A, Coles H, Stern C, Pearson T. Double blind trial of recombinant human erythropoietin in preterm infants. Arch Dis Child 1993; 68: 291-299.
4. Shannon K, Mentzer W, Abels R, Freeman P, Newton N, Thompson D. Recombinant human erythropoietin in the anemia of prematurity: Results of a placebo controlled pilot study. J Pediatr 1991; 118: 949-955.
5. Stockman J. Erythropoietin: off again, on again. J Pediatr 1988, 112: 906-908.
6. Stockman III J, Graeber J, Clark D, Mc Clellan K, Garcia J, Kavey R Anemia of prematurity: determinants of the erythropoietin response. J Pediatr 1984; 105: 786-792.
7. Nathan D, Oski F, Erythrocyte and its disorders in hematology of infart and childhood. Philadelphia: Saunders, 1993; 20.
8. Gallagher P, Ehernkrans R. Administración de la eritropoyetina contra la anemia de la prematurez. Clin Perinatol 1993 ; 1: 183.
9. Vassilik S, George K, Elizabeth D. In which neoantes does early recombinant human erythropoietin treatment prevent anemia of prematurity: results of a randomized controlled study. Pediatr Res 1993; 34: 679-683.
10. Ohis R, Christensen R. Recombinant erythropoietin compared with erythrocyte in the treatment of the anemia of the prematurity. J Pediatr 1991; 119: 781-787.
11. Carnielli V, Montini G, Da Riol R, Dall'Amico R, Cantarutti F. Effect of high doses of human recombinant erythropoietin on the need for blood transfusion in preterm infants. J Pediatr 1992; 121: 98-102.
12. Shannon K, Menzer W, Abels R, Wertz M, Thayer-Moriyama J, Yu Li W. Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: a pilot study. J Pediatr 1992; 120: 586-592.
13. Ohls R, Hunter D, Christensen R. A randomized, double blind, placebo controlled trial of recombinant erythropoietin in treatment of the anemia of bronchopulmonary displasia. J Paediatr 1993; 123: 996-1000
14. Phibbs R, Shannon K, Mentzer W. Potential for treatment of anemia of prematurity with recombinant human erythropoietin: preliminary results. Acta Haematol 1992; 87: 28-32.
15. Strauss R. Erythropoetin and neonatal anemia. N Engl J Med 1994; 330: 1227-1228.
16. Maier R, Obladen M, Scigalla P, Linderkamp O, Duc G, Hieronimi G, et al. The effect of epoietin beta (recombinant human erythropoietin) on the need for transfusion in very low birth weight infants. N Engl J Med 1994; 330: 1173-1178.
17. Halperin D, Wacker P, Lacourt G, Félix M, Babel J, Aapro M, et al. Effects of recombinant human erythropoietin in infants with the anemia of the prematurity: a pilot study . J Pediatr 1990; 116: 779-786.
18. Emmerson A, Coles H, Stern C, Pearson T. Double blind trial of recombinant human erythropoietin administration on peripheral blood neutrophil counts of premature infants J Pediatr 1994; 124: 467.
19. Mizuno S, Sasaki J, Suzuki Ch, Kono H, Kojima S. Effect of recombinant human erythropoietin administration on peripheral blood neutrophil counts of premature infants. J Pediatr 1994; 124: 467-470.
20. Frued W. The liver as a source of extrarenal erythropoietin production. Blood 1972; 40: 671-675.
21. Shannon K, Keith J, Mentzer W, Ehrenkranz R, Bron M, Widness J, et al. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low weight preterm infants. Pediatr 1995; 95: 1-8.
22. Brown M, Berman E, Luckey D. Prediction of the need of transfusion during anemia of prematurity. J Pediatr 1990; 116: 773-778.
23. a edicion. Buenos Aires, Panamencana, 1987; 434
24. Shapiro S, Wilk M, Chen J. A comparative study of various test for normality. Am Stat Asoc J 1968; 134-1372.
25. D'Agostinio R, Belanger A, D'Agostino R Jr. A suggestion for using powerful and informative tests of normality Am Stat Asoc J 1990; 44: 316-321.
26. a edición 1989; 252-253.
27. a edición 1989; 142-145.
28. a edición 1989; 89-95.
29. Agresti A. An introduction to categorical data analysis. Nueva York. John Wiley 1996; 39-44.
30. Strauss R. Red blood cell transfusion practices in the neonate. Clin Perinatal 1995; 22: 641-655.
31. Ziegler H. Body composition of the reference fetus. Growth 1976; 40: 329.
32. Ohls R. Christensen R. Recombinant erythropoitein compared with erythrocyte transfusion in the treatment of the anemia of prematurity. J Pediatr 1991; 119: 781-788.
33. Brown M, García J, Phibbs, Dallman P. Decreased response of plasma immunoreactive erythropoietin to "available oxygen" in anemia of prematurity . J Pediatr 1984; 105: 793-798.
34. Tipple M, Bland L, Murphy J. Sepsis associated with transfusion of red cells contaminated with Yersinia enterocolítica. Transfusion 1990; 30: 207-213.
35. De Palma L, Luban N. Blood components therapy in the perinatal period: guidelines and recommendations. Semin Perinatol 1990; 14: 403-415.
36. Holland P. Prevention of transfusion associated graft versus host disease. Arch Pathol Lab Med 1989; 113: 285-291.
37. Meyer M, Meyer J, Cammerfold A, Hann F, Sive A, Moller G, et al. Recombinant human erythropoietin in the treatment of the anemia of the prematurity: results of a double blind trial, placebo controlled study. Pediatr 1994; 93: 918-923.
38. Phibbs R, Kieth J. Recombinant human erytropoietin stimulates erythropoiesis and reduces transfusions in preterm infants. Clin Perinatol 1984; 11: 489-510.
39. Ohls R, Osborne R, Christensen R. Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: A randomized controlled trial. J Pediatr 1995; 126: 421-426.